AltMountain

Hamilton Square Biotech Partners (Offshore), LP

Emerging

Hamilton Square Biotech Partners (Offshore), LP is a private equity fund based in Princeton, New Jersey. According to its most recent Form D, filed Nov 13, 2025, it has sold $4,472,500 of interests to 2 investors since its first sale in Jul 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Hamilton Square Biotech Partners GP, LLC; Hamilton Square Partners Management, LP; David Tukey.

Total raised
$4,472,500Cumulative sales reported on Form D
Investors
2
First sale
Jul 14, 2025
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Hamilton Square Biotech Partners GP, LLC; Hamilton Square Partners Management, LP; David Tukey
Latest Form D
Nov 13, 2025

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Nov 13, 2025Form D/A (amendment)$4,472,5002SEC.gov ↗
Jun 3, 2025Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 3, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Vehicles of this fund (2)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
Hamilton Square Biotech Partners (Offshore), LP (main vehicle on this page)2069766Princeton, New Jersey$4,472,5002$0Nov 13, 2025
Hamilton Square Biotech Partners, LP2069759Princeton, New Jersey$510,0001$0Nov 13, 2025

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Hamilton Square Biotech Partners (Offshore), LP, the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Raise history: Hamilton Square Biotech Partners, LP

FiledFilingTotal raisedInvestorsSource
Nov 13, 2025Form D/A (amendment)$510,0001SEC.gov ↗
Jun 3, 2025Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 3, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Hamilton Square Biotech Partners (Offshore), LP

What is the minimum investment for Hamilton Square Biotech Partners (Offshore), LP?

Hamilton Square Biotech Partners (Offshore), LP's latest Form D, filed Nov 13, 2025, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Hamilton Square Biotech Partners (Offshore), LP?

Hamilton Square Biotech Partners (Offshore), LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Hamilton Square Biotech Partners (Offshore), LP raised?

Hamilton Square Biotech Partners (Offshore), LP reports $4,472,500 sold from 2 investors on its Form D filed Nov 13, 2025. This is cumulative sales since the offering began, not current assets or performance.

Where is Hamilton Square Biotech Partners (Offshore), LP based?

Hamilton Square Biotech Partners (Offshore), LP is based in Princeton, New Jersey and is managed by Hamilton Square Partners Management, LP.

When did Hamilton Square Biotech Partners (Offshore), LP launch?

Hamilton Square Biotech Partners (Offshore), LP reports its first sale in Jul 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every private equity fund

Raised more than 68% of the 215 private equity funds based in New Jersey, and more than 33% of all 8,931 that report sales.

Other funds with the same team

More private equity funds in Princeton

Similar-size private equity funds in New Jersey

All private equity funds in New Jersey